Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A New Chromogenic Assay (HemosIL ThromboPath) Is Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway. Results of a Multicenter Study.

Pierre A. Toulon, Mikhail Smirnov, Mark Triscott, Armando Tripodi

Blood (2007) 110 (11): 1626.

https://doi.org/10.1182/blood.V110.11.1626.1626

Published: 2007

Journal Articles

Optimization of One-Stage Coagulation Factor Assays: Improved Accuracy and Precision over an Extended Linear Range.

Janos Polgar, PhD, Jack Havelick, Qun Li, Nathalie Laurent, Mahesh Unalkat, Denise Matte, Zina Gruman, Pamela Haley, Edith Doenges, Christopher Holland, Ph.D., Istvan Csapo, Colleen Crowly, Mary Doyle, Ph.D., Mark Triscott, Ph.D.

Blood (2007) 110 (11): 3933.

https://doi.org/10.1182/blood.V110.11.3933.3933

Published: 2007

Journal Articles

A Highly Accurate and Linear Clauss Fibrinogen Assay Provides Increased Clinical Value for Patient Reporting throughout the 30 – 1000 mg/dL Medical Decision-Making Range.

Janet Callahan, Nathalie Laurant, Sam Arcidiacono, Janos Polgar, Doyle Mary, Mark Triscott

Blood (2007) 110 (11): 3935.

https://doi.org/10.1182/blood.V110.11.3935.3935

Published: 2007

Journal Articles

PT and INR Interference by the Antibiotic Daptomycin in Commercial Thromboplastin Reagents: Dependence on Phospholipid Composition.

Kevin Cawthern, PhD, Ralph Bottenus, Ph.D., Dharini Rawal, MS, Mark Triscott, Ph.D.

Blood (2006) 108 (11): 4129.

https://doi.org/10.1182/blood.V108.11.4129.4129

Published: 2006

Journal Articles

Liquid Heparin Assay: A Straightforward Approach for Monitoring the Clinical Use of Heparins.

Chun Kung, PhD, Jagadeesh Gabbeta, PhD, Valeri Krougliak, Ph.D., Emmanuel Quiazon, B.S., Mark Triscott, Ph.D.

Blood (2006) 108 (11): 890.

https://doi.org/10.1182/blood.V108.11.890.890

Published: 2006

NARROW

A New Chromogenic Assay (HemosIL ThromboPath) Is Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway. Results of a Multicenter Study.

Optimization of One-Stage Coagulation Factor Assays: Improved Accuracy and Precision over an Extended Linear Range.

A Highly Accurate and Linear Clauss Fibrinogen Assay Provides Increased Clinical Value for Patient Reporting throughout the 30 – 1000 mg/dL Medical Decision-Making Range.

PT and INR Interference by the Antibiotic Daptomycin in Commercial Thromboplastin Reagents: Dependence on Phospholipid Composition.

Liquid Heparin Assay: A Straightforward Approach for Monitoring the Clinical Use of Heparins.

Email alerts

ASH Publications

American Society of Hematology

A New Chromogenic Assay (HemosIL ThromboPath) Is Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway. Results of a Multicenter Study.

Optimization of One-Stage Coagulation Factor Assays: Improved Accuracy and Precision over an Extended Linear Range.

A Highly Accurate and Linear Clauss Fibrinogen Assay Provides Increased Clinical Value for Patient Reporting throughout the 30 – 1000 mg/dL Medical Decision-Making Range.

PT and INR Interference by the Antibiotic Daptomycin in Commercial Thromboplastin Reagents: Dependence on Phospholipid Composition.

Liquid Heparin Assay: A Straightforward Approach for Monitoring the Clinical Use of Heparins.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only